Search The Medical Knowledge Base

Search:

Medical News by Category

Non Small Cell Lung Cancer News

• Nexavar (Bayer/Onyx) fails to improve overall survival in MISSION study for NSCLC
  

  Published: Tuesday 22 May 2012

• NICE recommends Tarceva (Roche) for NSCLC
  

  Published: Thursday 10 May 2012

• Iressa (AstraZeneca) is withdrawn from US market for NSCLC
  

  Published: Wednesday 09 May 2012

• Benefits of Avastin (Roche) for older patients with NSCLC are not clear
  

  Published: Wednesday 18 April 2012

• Nexavar (Bayer HealthCare) effective in patients with Non-Small Cell Lung Cancer
  

  Published: Wednesday 11 January 2012

• Cobas EGFR Mutation test (Roche) receives CE mark for NSCLC testing
  

  Published: Saturday 03 December 2011

• Erbitux (Merck Serono/BMS) effective in NSCLC patients with EGFR mutation
  

  Published: Friday 04 November 2011

• EU approves Alimta as continuation maintenance therapy in non squamous NSCLC
  

  Published: Saturday 29 October 2011

• TG 4010 combination raises progression free survival in Non Small Cell Lung Cancer patients
  

  Published: Saturday 22 October 2011

• Adventrx Pharma discontinues Exelbine for Non Small Cell Lung Cancer
  

  Published: Tuesday 04 October 2011

• Higher radiation dose plus Erbitux not beneficial for Lung Cancer patients
  

  Published: Tuesday 04 October 2011

• CHMP recommends Alimta for continuation maintenance therapy in NSCLC
  

  Published: Monday 03 October 2011

• Alimta maintenance therapy positive in elderly NSCLC patients
  

  Published: Tuesday 27 September 2011

• Tarceva approved in EU as first line treatment against NSCLC with EGFR-mutations
  

  Published: Friday 16 September 2011